e-Article
Characterizing the Development of Secondary Myelodysplastic Syndrome (MDS) with Antecedent or Concurrent Chronic Lymphocytic Leukemia (CLL) in the Era of Small Molecule Inhibitors for the Treatment of CLL
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:4071-4073
Subject
Language
ISSN
0006-4971